# FDA Inspection 1122823 - OneBlood Inc. - March 12, 2020

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/12d47ce1-76c7-4a4a-8191-c1c50ba32c41
Source feed: FDA_Inspections

> FDA Inspection 1122823 for OneBlood Inc. on March 12, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122823
- Company Name: OneBlood Inc.
- Inspection Date: 2020-03-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1274844 - 2025-06-09](https://www.keypedia.com/records/fda_inspections/oneblood-inc/d8f0a6e3-db87-4bf5-a4cd-c8e2202535d0)
- [FDA Inspection 1274844 - 2025-06-09](https://www.keypedia.com/records/fda_inspections/oneblood-inc/3fe5ef5e-41f1-4766-85da-afbc75a016e4)
- [FDA Inspection 1056639 - 2018-05-10](https://www.keypedia.com/records/fda_inspections/oneblood-inc/57c4b78c-1873-44ac-960b-41f1568ebfe4)

Company: https://www.keypedia.com/companies/oneblood-inc/78ce3482-2625-46c8-a970-5501738e420a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d